Tumor necrosis factor-α antibodies (infliximab, adalimumab and certolizumab) in Crohn's disease: systematic review and meta-analysis

INTRODUCTION: This meta-analysis compares the effectiveness and safety of tumor necrosis factor α (TNF-α) antibodies (infliximab, adalimumab and certolizumab) with either a placebo or each of them in the treatment of Crohn's disease (CD). MATERIAL AND METHODS: A systematic review of literature...

Descripción completa

Detalles Bibliográficos
Autores principales: Kawalec, Paweł, Mikrut, Alicja, Wiśniewska, Natalia, Pilc, Andrzej
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Termedia Publishing House 2013
Materias:
Meta-analysis/Systematic review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3832823/
https://www.ncbi.nlm.nih.gov/pubmed/24273556
http://dx.doi.org/10.5114/aoms.2013.38670

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3832823/
https://www.ncbi.nlm.nih.gov/pubmed/24273556
http://dx.doi.org/10.5114/aoms.2013.38670

Ejemplares similares